Why the study?
To investigate the relationship between residual SYNTAX score and contrast-induced nephropathy development in NSTEMI patients with normal or near-to-normal LVEF undergoing PCI.
Is residual SYNTAX score associated with the development of contrast-induced nephropathy in patients with NSTEMI and preserved LVEF undergoing PCI?
Is residual SYNTAX score associated with the development of contrast-induced nephropathy in patients with NSTEMI and preserved LVEF undergoing PCI?
A higher residual SYNTAX score independently predicts the development of contrast-induced nephropathy in NSTEMI patients with preserved LVEF undergoing PCI.
Answers are grounded in this paper and cite their sources.
Residual SYNTAX score may aid CIN risk stratification after NSTEMI PCI; hypothesis-generating and requires prospective validation.
The purpose of this study is to investigate the relation between residual SYNTAX score (rSS) and contrast-induced nephropathy (CIN) development in patients with non-ST segment elevation myocardial infarction (NSTEMI) with normal or near-to-normal left ventricular ejection fraction (LVEF) who underwent percutaneous coronary intervention (PCI). A total of 306 patients who underwent PCI with NSTEMI were included in our study. SYNTAX scores were calculated for the periods before and after PCI. Patients were divided into 2 groups as developed CIN following PCI (CIN +) and patients did not (CIN −). Fifty-four (17.6%) of patients who were included in the study developed CIN. Age ( P = .001) and rSS ( P = .002) were significantly higher and LVEF was lower ( P = .034) in the CIN (+) group. Age ( P = .031, odds ratio [OR]: 1.031, 95% CI, 1.003-1.059) and rSS ( P = .04, OR: 1.036, 95% CI, 1.002-1.071) were independent predictors for CIN. In receiver operating characteristic analyses, when the cutoff value of rSS was taken as 3.5, it determined CIN with 79% sensitivity and 65% specificity. Contrast-induced nephropathy may develop more frequently in patients with increased rSS value. The rSS may be useful to follow-up these patients for CIN development.
No takes yet. Share an insight, caveat, or question.
Küçükosmanoğlu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: